Caligor Coghlan Revenue and Competitors

Austin, TX USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Caligor Coghlan's estimated annual revenue is currently $16.7M per year.(i)
  • Caligor Coghlan's estimated revenue per employee is $201,000

Employee Data

  • Caligor Coghlan has 83 Employees.(i)
  • Caligor Coghlan grew their employee count by -13% last year.

Caligor Coghlan's People

NameTitleEmail/Phone
1
VPReveal Email/Phone
2
VP UK/EUReveal Email/Phone
3
Associate Program DirectorReveal Email/Phone
4
Global Director Commercial OperationsReveal Email/Phone
5
Director LogisticsReveal Email/Phone
6
Global Director, Clinical Supply CommercialReveal Email/Phone
7
Chief Business OfficerReveal Email/Phone
8
Program ManagerReveal Email/Phone
9
Production ManagerReveal Email/Phone
10
Clinical Supplies Project ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$26.7M13320%N/AN/A
#2
$13.5M676%N/AN/A
#3
$16.1M80-2%N/AN/A
#4
$62.5M0N/AN/AN/A
#5
$10.1M506%N/AN/A
#6
$119.4M59427%N/AN/A
#7
$22.9M1148%N/AN/A
#8
$92.9M4628%N/AN/A
#9
$11.3M56-8%N/AN/A
#10
$7M356%N/AN/A
Add Company

What Is Caligor Coghlan?

Whether you need comparator drugs, rescue medications, combination therapies, ancillary supplies, or logistical support for worldwide clinical trials no one compares to Caligor. We are a trusted partner, helping major pharmaceutical and biotechnology companies meet their specialized drug sourcing requirements—so they can focus on improving patient health.

keywords:N/A

N/A

Total Funding

83

Number of Employees

$16.7M

Revenue (est)

-13%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Caligor Coghlan News

2022-03-22 - NLS Pharmaceutics Announces Early Access Program (EAP ...

ZURICH, SWITZERLAND / ACCESSWIRE / March 28, 2022 · About Idiopathic Hypersomnia (IH) · About Caligor Coghlan Pharma Services (CCPS) · About NLS...

2017-11-19 - Diversis Capital-owned Caligor Acquires The Coghlan Group

Caligor Holdco, LLC., announced today the acquisition of The Coghlan Group, a leading materials management service company for clinical trials. This strategic acquisition specifically adds deep domain expertise in packaging, labeling, distribution, storage and returns, and destruction services o ...

2016-04-11 - Caligor Rx Receives Majority Investment from Diversis Capital

Caligor Rx, Inc., a Secaucus, New Jersey-based provider of services for pharmaceutical and biotechnology companies to maximize the value of their clinical supply chain investments, has received a majority investment from Diversis Capital, LLC. The financial terms of the transaction were not dis ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$13.5M9080%N/A
#2
$31.2M953%N/A
#3
$20.4M97-6%N/A
#4
$26.7M99-5%N/A
#5
$7.5M1132%N/A